Desk›Services› Johnson Pharmacare Ltd
Johnson Pharmacare Ltd
BSE 532154 · NSE JOHNPHARMA · ISIN INE560F01022 · Group X · Active
Services › Services › Commercial Services & Supplies › Diversified Commercial Services
₹0.46
+0.00%
BSE close, 28 August 2026
₹25.30 cr
55.0 cr shares · Micro cap
₹25.30 cr
as published
-0.5× · 0.45×
EPS ₹-1.03 · BV ₹1.02
— / -55.73
₹ cr, as filed
5
2 selected · 40%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -45.9% |
|---|---|
| Against 52-week low | +2.2% |
| Day change | +0.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-1.03 |
|---|---|
| Price / earnings | -0.45× |
| Price / book | 0.45× |
| Book value — derived, price ÷ P/B | ₹1.02 |
| Return on equity | -100.12% |
| Operating margin | — |
| Net margin | — |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -100.00%
- ROE as published
- -100.12%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | — | -1.10 | -0.02 | — | — |
| Mar-26 · Q | — | -55.61 | -1.01 | — | — |
| FY25-26 | — | -55.73 | -1.01 | — | — |
Quarter on quarter
- Net profit, quarter on quarter
- +98.0%
Disclosure profile 5 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| Newspaper Publication | 1 |
| Other Update | 1 |
| Registered Office | 1 |
| Procedural sub-total | 3 |
| Total | 5 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
5 filings · 2 selected · busiest 2026-08-13
Filing rhythm · the twelve most recent
2026-08-112026-08-14
SelectedProcedural
Filings
5 in the window · 4 earlier on record
-
14 August 2026 ·
Newspaper Publication
Pursuant to regulation 47 of LODR, 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June, 2026.
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30Th, 2026.
Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
13 August 2026 ·
Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th, 2026 And Along With Limited Review Report Thereon.
Submission of Un-Audited Financial Results for the Quarter ended on June 30th 2026 and along with Limited Review Report Thereon.
Result / Financial Results View filing →
-
13 August 2026 ·
532154 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday, 13Th August, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
UN-AUDITED FINANCIAL RESULTS The Board of Director have considered and approved the Un-Audited Financial Results along with Limited Review Report thereon for quarter ended on June 30th, ....
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026 ·
Change in Registered Office Address
The Exchange and Investors are hereby informed that boards of directors of the company had accorded thier approval for shifting of Registered Office of the Company from Existing Address ....
Company Update / Change in Registered Office Address View filing →
RSS feed for Johnson Pharmacare Ltd · the 50 most recent filings